150 related articles for article (PubMed ID: 12803806)
1. Gas chromatography-mass spectrometry-single ion monitoring measurement of 11-nor-delta 9-tetrahydrocannabinol-carboxylic acid in urine.
Boldis O; Kocsis G; Gachályi A; Furész J
J Chromatogr Sci; 2003 Apr; 41(4):190-4. PubMed ID: 12803806
[TBL] [Abstract][Full Text] [Related]
2. Detection and quantitation of urinary 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid, a metabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragmentography.
Paul BD; Mell LD; Mitchell JM; McKinley RM; Irving J
J Anal Toxicol; 1987; 11(1):1-5. PubMed ID: 3029505
[TBL] [Abstract][Full Text] [Related]
3. Gas chromatographic-mass spectrometric quantitation of urinary 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid after derivatization by direct extractive alkylation.
Lisi AM; Kazlauskas R; Trout GJ
J Chromatogr; 1993 Aug; 617(2):265-70. PubMed ID: 8408392
[TBL] [Abstract][Full Text] [Related]
4. Combination of liquid chromatography with ultraviolet detection and gas chromatography with electron-capture detection for the determination of delta 9-tetrahydrocannabinol-11-oic acid in urine.
Karlsson L; Roos C
J Chromatogr; 1984 Mar; 306():183-9. PubMed ID: 6325483
[TBL] [Abstract][Full Text] [Related]
5. Identification of 11-Nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine by ion trap GC-MS-MS in the context of doping analysis.
Caballero GM; D'Angelo C; Fraguío MS; Centurión OT
J Chromatogr Sci; 2004; 42(10):540-4. PubMed ID: 15768841
[TBL] [Abstract][Full Text] [Related]
6. Rapid method for the GC/MS confirmation of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine.
Baker TS; Harry JV; Russell JW; Myers RL
J Anal Toxicol; 1984; 8(6):255-9. PubMed ID: 6097767
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of urine quantitative 11-nor-delta-9 tetrahydrocannabinol-9-carboxylic acid to determine abstinence from marijuana smoking.
Bell R; Taylor EH; Ackerman B; Pappas AA
J Toxicol Clin Toxicol; 1989; 27(1-2):109-15. PubMed ID: 2549268
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantification of low concentrations of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from minimal amounts of urine.
Musshoff F; Daldrup T
Int J Legal Med; 1991; 104(5):263-6. PubMed ID: 1664232
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in biological samples by gas chromatography tandem mass spectrometry (GC/MS-MS).
Chiarotti M; Costamagna L
Forensic Sci Int; 2000 Oct; 114(1):1-6. PubMed ID: 10924845
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated extraction of the main tetrahydrocannabinol metabolite, 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid, from human urine and its identification by gas chromatography-mass spectrometry in the sub-nanogram range.
Lemm U; Tenczer J; Baudisch H; Krause W
J Chromatogr; 1985 Aug; 342(2):393-8. PubMed ID: 2997252
[No Abstract] [Full Text] [Related]
11. [Routine detection of the THC metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in forensic practice].
Hanke M; Megges G
Z Rechtsmed; 1983; 90(2):105-8. PubMed ID: 6312709
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of a tetrahydrocannabinol metabolite in urine by gas chromatography.
Whiting JD; Manders WW
J Anal Toxicol; 1982; 6(1):49-52. PubMed ID: 6281576
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of 11-nor-delta 9-tetrahydrocannabinol in urine as its t-butyldimethylsilyl derivative using GC/MS.
Clouette R; Jacob M; Koteel P; Spain M
J Anal Toxicol; 1993; 17(1):1-4. PubMed ID: 8381495
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of 11 -nor-delta9-tetrahydrocannabinol-9-carboxylic acid with GC-MS in urine collected for doping analysis.
De Cock KJ; Delbeke FT; De Boer D; Van Eenoo P; Roels K
J Anal Toxicol; 2003 Mar; 27(2):106-9. PubMed ID: 12670005
[TBL] [Abstract][Full Text] [Related]
15. Gas chromatographic-mass spectrometric methods of analysis for detection of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in biological matrices.
Bronner WE; Xu AS
J Chromatogr; 1992 Sep; 580(1-2):63-75. PubMed ID: 1328271
[TBL] [Abstract][Full Text] [Related]
16. Interference in GC/MS confirmation of delta-9-tetrahydrocannabinol-9-carboxylic acid by a secondary tetrahydrocannabinol metabolite.
Podkowik BI; Kippenberger DJ; Smith ML
Clin Chem; 1991 Jul; 37(7):1307-8. PubMed ID: 1649710
[No Abstract] [Full Text] [Related]
17. Confirmation of cannabis abuse by the determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine with high-performance liquid chromatography and electrochemical detection.
Bourquin D; Brenneisen R
J Chromatogr; 1987 Feb; 414(1):187-91. PubMed ID: 3033002
[No Abstract] [Full Text] [Related]
18. [Detection of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in urine using thin-layer chromatography].
Nováková E
Soud Lek; 1997 Feb; 42(1):5-8. PubMed ID: 9221514
[TBL] [Abstract][Full Text] [Related]
19. Analysis of urine for 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using Sep-PAK cartridges for sample cleanup.
Nakamura GR; Stall WJ; Masters RG; Folen VA
Anal Chem; 1985 Jun; 57(7):1492-4. PubMed ID: 2994522
[No Abstract] [Full Text] [Related]
20. Gas chromatography/tandem mass spectrometry measurement of delta 9-tetrahydrocannabinol, naltrexone, and their active metabolites in plasma.
Nelson CC; Fraser MD; Wilfahrt JK; Foltz RL
Ther Drug Monit; 1993 Dec; 15(6):557-62. PubMed ID: 8122294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
